Wednesday Morning Movers: Gilead Sciences, Myriad Genetics Tumble Following Earnings
February 04, 2015 at 09:39 AM EST
Myriad Genetics, Inc. (NASDAQ: MYGN) -15% - Reported Q2 EPS, retirement of President, CEO Meldrum. Downgraded at Credit Suisse and ...